$Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity$

Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity

BackgroundObesity is a frequent and significant risk factor for venous thromboembolism (VTE) among hospitalized adults. Pharmacologic thromboprophylaxis can help prevent VTE, but real-world effectiveness, safety, and costs among inpatients with obesity are unknown.ObjectiveThis study aims to compare...

Full description

Bibliographic Details
Main Authors:	Alpesh Amin, Alex Kartashov, Wilson Ngai, Kevin Steele, Ning Rosenthal
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	thromboprophylaxis obesity medical inpatients enoxaparin unfractionated heparin cost analyses
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1163684/full

Similar Items

Randomized, Blinded Trial Comparing Enoxaparin with Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention
by: Hosein Vakili, et al.
Published: (2007-04-01)

Randomized, Blinded Trial Comparing Enoxaparin with Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention
by: Hosein Vakili, et al.
Published: (2007-07-01)

Unfractionated Heparin with Sequential Enoxaparin in Patients with Complex Coronary Artery Lesions during Percutaneous Coronary Intervention
by: Zhi-Zhong Li, et al.
Published: (2018-01-01)

Enoxaparin versus Unfractionated Heparin for the Perioperative Anticoagulant Therapy in Patients with Mechanical Prosthetic Heart Valve Undergoing Non-Cardiac Surgery
by: Luminita Iliuta, et al.
Published: (2022-08-01)

Low-Dose Unfractionated Heparin with Sequential Enoxaparin in Patients with Diabetes Mellitus and Complex Coronary Artery Disease during Elective Percutaneous Coronary Intervention
by: Ji Huang, et al.
Published: (2018-01-01)

Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study
by: Khalid Al Sulaiman, et al.
Published: (2022-12-01)

Comparsion of influence of enoxaparin with unfractioned heparin on acute myocardial infarction with ST-segment elevation
by: Seyed Abdolhossein Tabatabaie, et al.
Published: (2009-12-01)

THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME
by: E. A. Smirnova, et al.
Published: (2017-01-01)

Prolongation of enoxaparin therapy to one month promotes recanalization of occlusively thrombosed deep veins
by: Natal'ya Mikhaylovna Vorob'eva, et al.
Published: (2011-08-01)

Bemiparin Versus Enoxaparin for Extended Thromboprophylaxis in COVID-19 Patients at High Risk of Venous Thromboembolism
by: Ahmet Can TOPÇU, et al.
Published: (2021-01-01)

Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure
by: Alpesh N. Amin, et al.
Published: (2024-02-01)

Therapeutic inefficacy of protocol driven intravenous unfractionated heparin infusion in the current era
by: Kayla Torppey, et al.
Published: (2023-10-01)

The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results?
by: Pieter M.M. De Kesel, et al.
Published: (2020-01-01)

Comparison of Two Nomograms of Unfractionated Heparin in Patients with Acute Coronary Syndrome
by: Moneyreh Modares Mosadegh, et al.
Published: (2013-02-01)

Comparison of Two Nomograms of Unfractionated Heparin in Patients with Acute Coronary Syndrome
by: Moneyreh Modares Mosadegh, et al.
Published: (2013-02-01)

Thromboprophylaxis in women with unexplained consecutive recurrent ‎miscarriages
by: Maysoon Sharief, et al.
Published: (2014-06-01)

Unfractionated heparin attenuated histone-induced pulmonary endothelial glycocalyx injury through Ang/Tie2 pathway
by: Jia Yin, et al.
Published: (2025-02-01)

Case report: Successful thromboprophylaxis with enoxaparin in a pregnant woman with internal jugular vein agenesis
by: Pierpaolo Di Micco, et al.
Published: (2022-11-01)

The efficacy and safety of enoxaparin: a meta-analysis
by: Hai-long Wang, et al.
Published: (2018-09-01)

Unfractionated heparin in ruptured aortic aneurysms – narrative review
by: Tiago F. Ribeiro, et al.
Published: (2024-05-01)

LMWHs have additional advantage over unfractionated heparin: no volume load
by: GP Koracevic
Published: (2009-10-01)

Comparison of Pregnancy Outcomes of Low Molecular Weight Heparin with Unfractionated Heparin in the Treatment of Recurrent Abortion Secondary to Antiphospholipid Syndrome
by: M Janghorbani, et al.
Published: (2013-09-01)

The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin—A Randomized, Controlled, Crossover Study
by: Liva K. Stuhr, et al.
Published: (2025-01-01)

Thromboprophylaxis after minimally invasive total knee arthroplasty: A comparison of rivaroxaban and enoxaparin
by: Shih-Hsiang Yen, et al.
Published: (2014-08-01)

Thiol-Ene Reaction of Heparin Allyl Ester, Heparin 4-Vinylbenzyl Ester and Enoxaparin
by: Richard T. Taylor, et al.
Published: (2022-09-01)

The Effect of Polybrene on an aPTT-based Lupus Anticoagulant Test in the Plasma of Patients Receiving Unfractionated Heparin
by: Chulalak Kongkan, et al.
Published: (2023-01-01)

Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia
by: Romanová T, et al.
Published: (2024-09-01)

Efficacy and safety of low molecular weight heparin compared to unfractionated heparin for chronic outpatient hemodialysis in end stage renal disease: systematic review and meta-analysis
by: Ghanshyam Palamaner Subash Shantha, et al.
Published: (2015-03-01)

A Comparative Study Assessing the Incidence and Degree of Hyperkalemia in Patients on Unfractionated Heparin versus Low-Molecular Weight Heparin
by: Naseralallah L, et al.
Published: (2024-12-01)

Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
by: Thompson David, et al.
Published: (2006-09-01)

Comparison of Enoxaparin versus Heparin among Patients Undergoing Elective Coronary Angiography via Radial Artery Access
by: Reza Kiani, et al.
Published: (2018-01-01)

Bullous hemorrhagic dermatosis induced by enoxaparin
by: Isa An, et al.
Published: (2017-01-01)

Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
by: Hind Harrak Lazrak, et al.
Published: (2017-06-01)

Unfractionated Heparin Enhances Sepsis Prognosis Through Inhibiting Drp1‐Mediated Mitochondrial Quality Imbalance
by: Ruixue Liu, et al.
Published: (2024-12-01)

Unfractionated heparin improves the clinical efficacy in adult sepsis patients: a systematic review and meta-analysis
by: Sifeng Fu, et al.
Published: (2022-01-01)

Influence of low molecular weight heparins on immune system of surgical patients
by: O O Budnyuk, et al.
Published: (2019-02-01)

Prescriber perceptions of the safety and efficacy of unfractionated heparin versus low molecular weight heparin in the acute treatment phase: a qualitative study
by: Danielle Green, et al.
Published: (2024-12-01)

Heparin versus enoxaparine for prevention of asymptomatic deep venous thrombosis after total knee arthroplasty
by: Adnan H. Hnoosh, et al.
Published: (2013-01-01)

Unfractionated heparin and mechanical thromboprophylaxis in hip arthroplasty
by: Flávio Luís Garcia, et al.
Published: (2015-08-01)

Thrombolysis versus unfractionated heparin for hemodynamically stable patients with pulmonary embolism: a systematic review and meta-analysis
by: N. A. Cherepanova, et al.
Published: (2022-09-01)